Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
new decrease » nn decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
Showing 1,141 - 1,160 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((new decrease) OR (we decrease)) ))', query time: 0.51s Refine Results
  1. 1141
    3D and 2D pose of the docked 4-hydroxyestrdiol diagram displaying a variety of interactions with enzyme’s active region.

    3D and 2D pose of the docked 4-hydroxyestrdiol diagram displaying a variety of interactions with enzyme’s active region. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1142
    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. positive controls Cisplatin and doxorubicin against other malignancy’ cell lines adherent monolayers.

    Cytotoxicity (as of %Control) IC<sub>50</sub> value (mean ±SD in µM) of the tested compounds vs. positive controls Cisplatin and doxorubicin against other malignancy’ cell lines ad... by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1143
    The role of glyoxalase system in methylglyoxal detoxification.

    The role of glyoxalase system in methylglyoxal detoxification. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1144
    IC<sub>50</sub> values (mean ±SD in μM) of <i><i>in vitro</i></i> DPPH-radical scavenging properties vs. ascorbic acid and antiinflammation propensities vs. indomethacin of the tested compounds.

    IC<sub>50</sub> values (mean ±SD in μM) of <i><i>in vitro</i></i> DPPH-radical scavenging properties vs. ascorbic acid and antiinflammation propensities vs. indomethacin of the tes... by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1145
    3D and 2D pose of the docked Shikonin diagram displaying a variety of interactions with enzyme’s active region.

    3D and 2D pose of the docked Shikonin diagram displaying a variety of interactions with enzyme’s active region. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1146
    Classification of inactive compounds.

    Classification of inactive compounds. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1147
    Active compounds identified as glyoxalase-I inhibitors.

    Active compounds identified as glyoxalase-I inhibitors. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1148
    The inhibitory activity of the most active compounds against Glo-I enzyme with less than 50 µM. Their supportive corresponding docking values on two different protocols are displayed.

    The inhibitory activity of the most active compounds against Glo-I enzyme with less than 50 µM. Their supportive corresponding docking values on two different protocols are display... by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1149
    3D and 2D pose of the docked Tolcapone diagram displaying a variety of interactions with enzyme’s active region.

    3D and 2D pose of the docked Tolcapone diagram displaying a variety of interactions with enzyme’s active region. by MohammedBashar Al-Qazzan (22439236)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1150
    Key significant pathways in the final models of self-compassion.

    Key significant pathways in the final models of self-compassion. by Eriko Takahashi (22608061)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1151
    S3 Table -

    S3 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 1152
    S5 Table -

    S5 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 1153
    S1 Table -

    S1 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 1154
    S2 Table -

    S2 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 1155
    Participant characteristics (<i>n</i> = 34).

    Participant characteristics (<i>n</i> = 34). by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 1156
    S4 Table -

    S4 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1157
    S6 Table -

    S6 Table - by Yong-Rae Kim (19797278)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1158
    The change of disease burden of CRD by sex in Fujian, 1990-2021.

    The change of disease burden of CRD by sex in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1159
    The change of disease burden of CRD by age groups in Fujian, 1990-2021.

    The change of disease burden of CRD by age groups in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1160
    The change of disease burden of CRD by categories in Fujian, 1990-2021.

    The change of disease burden of CRD by categories in Fujian, 1990-2021. by Yanrong Yin (14292683)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: